In March 2024, the FDA approved resmetirom for MASH patients with liver scarring
Ratner RE, Want LL, Fineman MS et al (2002) Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes
The vultures are onto something good: bone marrow is criminally delicious
Many people wont see significant weight loss until month four or five when they reach the higher doses, explains Homan
Experts Urge Long-Term Strategies Beyond Medication Based on the findings, the authors conclude: "This evidence cautions against short term use of weight management medications, emphasizes the need for further research into cost effective strategies for long term weight control, and reinforces the importance of primary prevention." A US researcher echoed these concerns in a linked editorial, writing that "The study findings cast doubt on the notion that GLP-1 receptor agonists are a perfect cure for obesity." "People taking GLP-1 receptor agonists should be aware of the high discontinuation rate and the consequences of cessation of medications," he adds
In todays fast-paced lifestyle, our skin faces daily stressors like pollution, sun exposure and ageing
